There are errors in the Funding statement. The correct Funding statement is as follows: CURACLE Co, Ltd., provided support for the study in the form of salary for HZ, and provided the CU06-1004 sample. The specific roles of this author are articulated in the ‘author contributions’ section. This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT, 2019R1C1C1003754), and the Ministry of Science, ICT & Future Planning (MSIP; NRF-2019R1A2C3007142). This work was also supported in part by the Brain Korea 21 (BK21) PLUS program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Reference
- 1. Bae C-R, Zhang H, Kwon Y-G (2020) The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice. PLoS ONE 15(12): e0243497. https://doi.org/10.1371/journal.pone.0243497 pmid:33275637
Citation: Bae C-R, Zhang H, Kwon Y-G (2021) Correction: The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice. PLoS ONE 16(4): e0249747. https://doi.org/10.1371/journal.pone.0249747
Published: April 5, 2021
Copyright: © 2021 Bae et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.